How much revenue does FDC make?

FDC reported 21.03 billion INR in revenue for fiscal year 2025, up 8.6% from 19.35 billion INR in fiscal year 2024. In Q3 2026 revenue was 4.65 billion INR.

Where does FDC make most of its revenue?

India: 85% of revenue by region in fiscal year 2025, followed by Others (12%).

What companies are similar to FDC?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Sanofi Cons Healthc IND L (SANOFICONR.BO), Sanofi India Limited (SANOFI.NS), Sun Pharma Advanced Research Company Limited (SPARC.NS), Novartis India Limited (NOVARTIND.BO).

FDC Limited (FDC.NS) Stock

About FDC Limited

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastroenterology, ophthalmology, anti-diabetics, cardiovascular care, respiratory care, gynaecology, dermatology, paediatrics, analgesics, vitamin...

At a glance

FDC reported revenue of 21.03 billion INR for fiscal year 2025, up 8.6% from fiscal year 2024, and net income of 2.67 billion INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 4.65 billion INR, up 0.1% from a year before. India was its largest region in fiscal year 2025, with 85% of revenue.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.